Medtech Reimbursement In The EU: The Early Bird Catches The Worm
Executive Summary
There is no “one size fits all” approach to gaining reimbursement in Europe – medtech companies must tailor their strategies to individual markets. A panel of reimbursement specialists at the recent IN3 meeting in Dublin advised companies planning market entry to do their homework, keep up to date with market developments, and think early.